Cargando…
Evaluating the Efficacy of Therapies in Patients With Coronavirus Disease 2019
There is a proliferation of clinical trials worldwide to find effective therapies for patients diagnosed with coronavirus disease 2019 (COVID-19). The endpoints that are currently used to evaluate the efficacy of therapeutic agents against COVID-19 are focused on clinical status at a particular day...
Autores principales: | Lin, Dan-Yu, Zeng, Donglin, Eron, Joseph J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454372/ https://www.ncbi.nlm.nih.gov/pubmed/32818962 http://dx.doi.org/10.1093/cid/ciaa1231 |
Ejemplares similares
-
Evaluating the Efficacy of Coronavirus Disease 2019
Vaccines
por: Lin, Dan-Yu, et al.
Publicado: (2020) -
Evaluating the Long-term Efficacy of Coronavirus Disease 2019 (COVID-19) Vaccines
por: Lin, Dan-Yu, et al.
Publicado: (2021) -
Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Lin, Dan-Yu, et al.
Publicado: (2021) -
Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?
por: Chamilos, Georgios, et al.
Publicado: (2020) -
Coronavirus disease 2019 and its vaccines: An update
por: Jeddy, Nadeem, et al.
Publicado: (2021)